BioNTech SE (BNTX) Treasury Shares (2019 - 2025)

BioNTech SE has disclosed Treasury Shares across 7 years of filings, most recently posting -$9.0 million for Q4 2025.

• Treasury Shares for Q4 2025 came in at -$9.0 million, up 2.47% year-over-year; the trailing twelve-month figure through Dec 2025 was -$9.0 million (up 2.47% YoY), and the FY2025 annual result was -$8.7 million, up 5.34% from the prior year.
• Treasury Shares came in at -$9.0 million for Q4 2025 at BioNTech SE, up from -$9.5 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of -$4.3 million in Q1 2022 to a low of -$11.8 million in Q3 2023.
• The 5-year median for Treasury Shares is -$9.2 million (2024), against an average of -$8.7 million.
• Across the five-year window, Treasury Shares slumped 175.96% in 2021 and grew 26.48% in 2025, its largest moves.
• BioNTech SE's Treasury Shares stood at -$4.3 million in 2021, then retreated by 24.39% to -$5.4 million in 2022, then slumped by 114.9% to -$11.6 million in 2023, then rose by 20.91% to -$9.2 million in 2024, then grew by 2.47% to -$9.0 million in 2025.
• The last three Treasury Shares figures came in at -$9.0 million (Q4 2025), -$9.5 million (Q3 2025), and -$9.3 million (Q2 2025), per Business Quant data.